of 4706
the 4200
in 3207
and 3084
to 2411
with 2173
be 1721
or 1569
patients 1537
a 1527
is 1396
should 1376
for 1223
not 840
dose 747
The 721
aripiprazole 694
In 633
epoetin 602
g/ 587
at 556
alfa 555
on 554
are 546
haemoglobin 542
may 540
ABILIFY 533
as 521
- 519
blood 482
by 463
has 456
dl 453
was 442
been 439
have 428
increased 419
1 418
treatment 404
clinical 382
mmol/ 380
other 378
that 378
than 368
you 366
if 358
an 356
section 342
used 329
, 317
. 313
no 305
If 303
IU/ 301
use 295
your 294
were 290
anaemia 288
(@@ 280
ing 279
this 279
from 278
risk 277
any 271
kg 269
+ 267
mg 266
renal 263
3 262
(see 260
per 257
10 254
OF 248
increase 244
BRISTOL-MYERS 243
12 236
SQUIBB 234
treated 234
Abseamed 233
administered 233
medicinal 233
therapy 232
who 232
recommended 230
administration 228
effects 228
times 226
2 225
symptoms 222
between 217
receiving 216
events 213
s 212
reported 203
ml 200
during 197
after 195
doctor 194
when 194
) 193
l) 192
30 189
ation 187
THE 181
Tel: 180
cancer 180
week 176
injection 172
trials 171
human 170
product 170
/ 169
one 166
1/ 165
ed 164
disorders: 162
including 161
take 160
intravenous 159
given 156
solution 156
(e. 155
there 154
compared 153
following 153
g. 152
pre-filled 152
studies 152
associated 151
incidence 150
al 149
doses 146
observed 146
x 145
re@@ 143
placebo-controlled 142
Aripiprazole 141
chronic 141
it 141
patient 141
s. 141
Patients 140
e 140
y 140
such 139
tablets 138
4 136
approximately 136
which 136
more 135
weeks 134
those 133
significant 132
(7.5 131
; 131
cell 131
failure 131
weight 130
adult 129
aripiprazole. 129
can 129
prior 128
When 127
s, 126
iron 125
effect 124
erythropoietin 124
surgery 124
EU/ 122
also 122
count 122
severe 122
-@@ 121
manic 121
patients. 121
until 121
), 120
vascular 120
13 119
level 119
< 116
ation, 116
adjustment 115
dose. 115
into 115
syringe 115
al@@ 114
chemotherapy 114
all 113
day 113
e, 113
6 112
Abraxane 112
dialysis 112
l). 112
below 111
less 111
AUC 110
concentration 110
levels 110
these 110
AUTHORISATION 109
e. 109
side 109
maximum 108
mg/ 108
pre@@ 107
ted 107
es 106
15 105
greater 105
heart 105
oral 105
t 105
adverse 104
antipsychotic 104
m 104
order 104
5 103
I 103
available 103
major 103
overall 103
study 103
tumour 103
50 102
Treatment 102
information 102
similar 102
autologous 101
target 101
: 100
AND 100
CYP3A4 100
e@@ 100
p@@ 100
pressure 100
taken 100
CYP2D6 99
adequate 99
maintenance 99
some 99
Epoetin 98
ine 98
potential 98
without 98
• 98
A 97
C@@ 97
It 97
data 96
over 96
at@@ 95
c@@ 95
contains 95
shown 95
about 94
ar@@ 94
higher 94
300 93
two 93
therapy. 92
There 91
aripiprazole, 91
controlled 91
it@@ 91
orodispersible 91
patients, 91
Bipolar 90
Hb 90
MEDICINAL 90
elective 90
hours 90
potent 90
studies, 90
14 89
se 89
1@@ 88
ate 88
disorders 88
three 88
caution 87
medicines 87
subcutaneous 87
treatment. 87
a, 86
con@@ 86
placebo 86
high 85
tell 85
MARKETING 84
before 84
but 84
tablet 84
clinically 83
low 83
reduction 83
y, 83
y@@ 83
2. 82
history 82
monitored 82
orthopaedic 82
placebo. 82
whose 82
25 81
concomitant 81
recombinant 81
trial, 81
ABILIFY. 80
Adult 80
phase: 80
predonation 80
reticulocyte 80
scheduled 80
th@@ 80
values 80
µl 80
0@@ 79
1. 79
> 79
efficacy 79
in@@ 79
least 79
st@@ 79
4. 78
active 78
haemodialysis 78
mean 78
red 78
very 78
a@@ 77
cases 77
These 76
cardiovascular 76
m@@ 76
04/ 75
276/ 75
This 75
considered 75
ia 75
its 75
ra@@ 75
se@@ 75
disease 74
had 74
rate 74
s) 74
8 73
However, 73
above 73
cannot 73
four 73
survival 73
t. 73
1.@@ 72
alfa. 72
baseline 72
body 72
dosage 72
ic 72
marrow 72
route 72
toxicity 72
cause 71
ing, 71
involving 71
moderate 71
sis 71
years 71
(6.2 70
0.@@ 70
desired 70
episodes 70
ia, 70
initial 70
paediatric 70
precautions 70
≥ 70
For 69
NAME 69
er@@ 69
especially 69
Abilify 68
ac@@ 68
concentrations 68
included 68
3. 67
75 67
Cmax 67
PRODUCT 67
taking 67
60 66
PARTICULARS 66
com@@ 66
sudden 66
Common: 65
DATE 65
could 65
ly 65
trials, 65
control 64
d 64
ur@@ 64
volume 64
D@@ 63
S. 63
S@@ 63
aripiprazole-treated 63
b@@ 63
de@@ 63
loss 63
under 63
200 62
bone 62
decreased 62
ent 62
reduced 62
route. 62
4.4 61
A. 61
ar 61
ation. 61
cells 61
course 61
g@@ 61
immediately 61
l), 61
must 61
non-@@ 61
response 61
sed 61
site 61
system 61
Do 60
Maintenance 60
Special 60
benefit 60
daily 60
exceeds 60
individual 60
known 60
mixed 60
n@@ 60
properties 60
range 60
s: 60
serum 60
thrombotic 60
weekly 60
100 59
4.4). 59
An 59
achieved 59
being 59
co@@ 59
demonstrated 59
ensure 59
healthy 59
ic@@ 59
thromboembolic 59
trial 59
up 59
2@@ 58
6. 58
agents 58
condition 58
di@@ 58
f@@ 58
hyper@@ 58
management 58
possible 58
primarily 58
sion 58
150 57
5. 57
combination 57
exceed 57
lithium 57
lower 57
m, 57
mo@@ 57
once 57
required 57
tes 57
tion 57
v@@ 57
E@@ 56
able 56
based 56
breast 56
c 56
factors 56
pregnant 56
te@@ 56
cerebrovascular 55
6.8 54
ABILIFY, 54
EPS 54
GYÓGYSZERKERESKEDELMI 54
KFT. 54
hepatic 54
inhibitors 54
most 54
ous 54
serotonin 54
signs 54
PHARMACEUTICAL 53
TO 53
do@@ 53
drive 53
month 53
poly@@ 53
safety 53
– 53
(< 52
5@@ 52
Keep 52
Oral 52
SPECIAL 52
ations 52
car@@ 52
ding 52
patients: 52
protect 52
treat 52
). 51
FOR 51
HOLDER 51
closely 51
first 51
liver 51
only 51
pain, 51
start 51
thrombosis 51
vitro 51
week. 51
(1.25 50
00 50
4.2 50
40,000 50
7.5 50
Correction 50
ability 50
allergic 50
ating 50
dl, 50
growth 50
important 50
maintain 50
necessary. 50
ol@@ 50
s; 50
special 50
symptomatic 50
their 50
use. 50
11 49
children 49
dose-dependent 49
es, 49
haloperidol 49
include 49
medical 49
ment 49
mental 49
months 49
multiple 49
need 49
par@@ 49
perforated 49
pharmacokinetics 49
products. 49
receptors 49
reports 49
unit 49
Red 48
differences 48
is@@ 48
muscle 48
myocardial 48
over@@ 48
00@@ 47
07/ 47
E 47
animal 47
ce 47
concomitantly 47
expected 47
experience 47
gain 47
id 47
pharmacist. 47
po@@ 47
rats 47
s@@ 47
stroke 47
therapy, 47
they 47
ting 47
total 47
24 46
412/ 46
5.1). 46
7 46
ated 46
bipolar 46
diabetes 46
disease, 46
does 46
elderly 46
ity. 46
me@@ 46
products 46
psychotic 46
units 46
valproate 46
18 45
Each 45
G@@ 45
H@@ 45
In@@ 45
O. 45
R. 45
ary 45
ation@@ 45
be@@ 45
dehydro-aripiprazole 45
difficulty 45
episode 45
monotherapy 45
overdose 45
sodium 45
to@@ 45
33 44
Cell 44
Pure 44
S 44
clo@@ 44
ers 44
i@@ 44
k 44
pack 44
patients) 44
reach 44
receive 44
sub@@ 44
syringes 44
tive 44
treatment, 44
28 43
49 43
8@@ 43
All 43
Therefore, 43
addition, 43
as@@ 43
deep 43
effective 43
either 43
indicated 43
inter@@ 43
lon@@ 43
necessary 43
through 43
throughout 43
ti@@ 43
tion, 43
un@@ 43
At 42
Erythropoietin 42
ON 42
What 42
anti@@ 42
ap@@ 42
blister 42
feel 42
h@@ 42
id@@ 42
ity 42
leaflet 42
ly, 42
machines 42
medicine 42
performed 42
possibility 42
progression 42
same 42
schizophrenia 42
su@@ 42
suspension 42
tion@@ 42
using 42
000 41
2.@@ 41
Haemoglobin 41
Kingdom 41
Medicines 41
Uncommon: 41
United 41
alfa, 41
binding 41
da@@ 41
day. 41
ex@@ 41
found 41
haematological 41
half-life 41
induced 41
insufficiency 41
insufficient 41
ma@@ 41
population 41
reaction 41
venous 41
well 41
y. 41
“ 41
0.5 40
21 40
22 40
3.@@ 40
40,000/ 40
9 40
B12 40
General 40
No 40
Reticulocyte 40
Subcutaneous 40
affect 40
anaemi@@ 40
anaemic 40
carefully 40
cells/ 40
divided 40
dose, 40
dy@@ 40
fibrosis 40
hypertension. 40
isolated 40
l@@ 40
o@@ 40
occur 40
occurs, 40
out@@ 40
package 40
peak 40
preventing 40
reactions 40
res 40
stages: 40
supplementation 40
ted. 40
ts 40
undergoing 40
vitamin 40
w 40
yet 40
Following 39
Other 39
Pharmaceutical 39
approved 39
causes 39
ch@@ 39
changes 39
death 39
did 39
dopamine 39
ec@@ 39
improvement 39
on@@ 39
or@@ 39
potentially 39
produc@@ 39
received 39
see 39
w@@ 39
we@@ 39
39 38
Due 38
L@@ 38
T@@ 38
common 38
d, 38
dosing 38
evidence 38
exten@@ 38
feeling 38
hep@@ 38
me, 38
metastatic 38
monitoring 38
pharmacokinetic 38
please 38
sa@@ 38
skin 38
starting 38
substance 38
t@@ 38
then 38
therapeutic 38
um 38
whether 38
3% 37
8. 37
Disorder, 37
Solution 37
Weight 37
acid 37
continue 37
der 37
es. 37
failure, 37
flu@@ 37
further 37
high@@ 37
ischaemic 37
medically 37
occurred 37
pneumon@@ 37
prescribed 37
re. 37
revealed 37
schizophrenic 37
sed, 37
significantly 37
time 37
transient 37
u@@ 37
unexplained 37
4@@ 36
Disorder 36
Europe 36
Ltd. 36
Not 36
Otsuka 36
P@@ 36
QT 36
Tablet 36
affinity 36
depres@@ 36
discontinuation 36
family 36
female 36
full 36
gain, 36
h 36
hypo@@ 36
ou@@ 36
steady-state 36
superior 36
te, 36
vial 36
7. 35
9. 35
Com@@ 35
W@@ 35
appropriate 35
disorder, 35
e) 35
ge@@ 35
op@@ 35
pharmacist 35
potassium 35
protein 35
ro@@ 35
toxic@@ 35
* 34
OR 34
Store 34
de 34
described 34
fe@@ 34
g 34
ial 34
lo@@ 34
ne@@ 34
normal 34
paclitaxel 34
r@@ 34
related 34
ses 34
sh@@ 34
suffer 34
where 34
10. 33
13@@ 33
As 33
FORM 33
INFORMATION 33
NUMBER(S) 33
Un@@ 33
abdominal 33
additional 33
aluminium 33
basis 33
cau@@ 33
children. 33
conditions 33
consideration 33
cy@@ 33
days 33
disorder 33
exposure 33
fo@@ 33
lead 33
mi@@ 33
obtained 33
oc@@ 33
pressure, 33
require 33
se. 33
tu@@ 33
um@@ 33
you. 33
& 32
(PRCA) 32
After 32
Re@@ 32
Sodium 32
d. 32
decrease 32
existing 32
fa@@ 32
inten@@ 32
ised 32
k@@ 32
king 32
measured 32
patient@@ 32
reduc@@ 32
si@@ 32
sti@@ 32
tions 32
vein 32
z@@ 32
"@@ 31
0 31
12. 31
450 31
47 31
9.5 31
Anaemia 31
How 31
Hypersensitivity 31
arter@@ 31
change 31
chemotherapy, 31
discomfort, 31
disposed 31
ent@@ 31
ev@@ 31
followed 31
ili@@ 31
inc@@ 31
interaction 31
le@@ 31
li@@ 31
line 31
local 31
malignant 31
ments 31
platelet 31
rare 31
remain 31
show 31
solid 31
status 31
supervision 31
sure 31
surgery, 31
t, 31
ten@@ 31
transfusions 31
typ@@ 31
urinary 31
(5.9 30
(8.1 30
0.62 30
20 30
4.3 30
4.8 30
6% 30
BATCH 30
Based 30
Fe2+/ 30
Iron 30
Moreover, 30
Overdose 30
Pregnancy 30
Road 30
Some 30
abnormal 30
achieve 30
against 30
age 30
alfa@@ 30
atic 30
cerebral 30
comparable 30
complications 30
contents 30
controls. 30
cyclosporin 30
d: 30
d; 30
deficiency, 30
doctor. 30
done 30
ently 30
epoetins 30
er, 30
erythropoiesis 30
erythropoietic 30
erythropoietins 30
evaluation 30
excluded. 30
failed 30
foetal 30
folate 30
group 30
having 30
headaches 30
ie@@ 30
life 30
limit@@ 30
listed 30
long 30
lu@@ 30
metabolism 30
mg) 30
min@@ 30
models 30
much 30
non-platinum 30
ogenicity 30
olog@@ 30
p 30
participating 30
periodically 30
peritoneal 30
plasma 30
popul@@ 30
pro@@ 30
programme 30
programme@@ 30
prophylax@@ 30
respectively. 30
rise 30
s). 30
sequelae 30
several 30
sive 30
started 30
statistically 30
steps 30
subjects, 30
surgical 30
sustained 30
ter 30
thereafter. 30
thrombosis, 30
thrombotic/ 30
tion: 30
transfusion 30
type 30
uncommon 30
various 30
warnings 30
" 29
(1 29
(alu/ 29
4.5). 29
4.9 29
6@@ 29
7% 29
CONDITIONS 29
Con@@ 29
European 29
Hyper@@ 29
Posology 29
Undesirable 29
activity 29
although 29
alu) 29
an@@ 29
ative 29
bound 29
conc@@ 29
discontinued. 29
ents 29
estimated 29
exposures 29
extensive 29
gen@@ 29
geno@@ 29
gets 29
group. 29
haloperidol@@ 29
hazard 29
indic@@ 29
injection. 29
lar@@ 29
medicin@@ 29
might 29
mortality 29
nausea, 29
nor 29
notice 29
ous@@ 29
patients). 29
posi@@ 29
pressu@@ 29
protein@@ 29
ran@@ 29
reg@@ 29
required. 29
routine 29
secondary 29
somnolence, 29
subjects 29
suff@@ 29
symptoms, 29
symptoms. 29
therefore 29
tribu@@ 29
urine 29
ve 29
via 29
weeks. 29
's 28
2% 28
3@@ 28
5.@@ 28
Interaction 28
OTHER 28
You 28
a). 28
agents, 28
analysis 28
ant. 28
antihypertensive 28
attack@@ 28
become 28
carbamazep@@ 28
carton 28
deaths 28
dec@@ 28
detectable 28
discontinue 28
do 28
elevated 28
en@@ 28
es: 28
even 28
face 28
fatal 28
groups 28
her@@ 28
highest 28
humans 28
increases 28
infarction 28
ingredients 28
ise 28
maintaining 28
mediated 28
no@@ 28
ole 28
people 28
reas@@ 28
rec@@ 28
recurrence 28
relevant 28
respon@@ 28
sensitivity 28
term 28
toxicity, 28
unc@@ 28
unlikely 28
week, 28
"mini" 27
%, 27
06 27
1HU 27
25@@ 27
26-week 27
26-week, 27
260 27
3.5% 27
4.8). 27
74 27
7@@ 27
A@@ 27
Be 27
Business 27
Highbridge 27
House 27
Hunton 27
LTD 27
Middlesex 27
NMS, 27
Oxford 27
Park, 27
SPOL. 27
Taking 27
UB8 27
Uxbridge 27
accidental 27
adolescents 27
adrenocortical 27
ance 27
antipsychotics, 27
anxi@@ 27
applied. 27
aspiration 27
because 27
bile 27
compar@@ 27
death, 27
dehydro-aripiprazole, 27
dyskinesia 27
exhibited 27
glucose 27
how 27
ia. 27
ing@@ 27
inhibitor 27
irregular 27
kg/ 27
mania 27
mellitus 27
mis@@ 27
mor@@ 27
olanzap@@ 27
packed 27
placebo-treated 27
post-marketing 27
pri@@ 27
psycho@@ 27
receptors. 27
saliv@@ 27
speech 27
stiffness 27
suicide 27
thoughts 27
water 27
white 27
will 27
(for 26
(≥ 26
12@@ 26
16 26
APPEAR 26
Alternatively, 26
IF 26
Manic 26
R@@ 26
containing 26
cul@@ 26
handling 26
il@@ 26
injections 26
les 26
lic@@ 26
marketed. 26
mic@@ 26
ml) 26
peripheral 26
phosphate 26
prescription. 26
re: 26
regard 26
single 26
sizes 26
ts. 26
5.2). 25
EXP 25
M@@ 25
Marketing 25
NUMBER 25
OUTER 25
USE 25
a. 25
agents. 25
care 25
contact 25
ded 25
dis@@ 25
each 25
ine, 25
last 25
like 25
out 25
reduce 25
sug@@ 25
test 25
yl@@ 25
14@@ 24
6.@@ 24
Any 24
Aplasia 24
Authorisation 24
EXPIRY 24
Read 24
ad@@ 24
amount 24
another 24
ar, 24
ch 24
comple@@ 24
corresponding 24
counts 24
date 24
de, 24
dizziness, 24
du@@ 24
emea. 24
europa. 24
form@@ 24
frequency 24
ide@@ 24
impairment 24
ir@@ 24
le, 24
light. 24
open@@ 24
production 24
provide 24
resulting 24
sen@@ 24
surface 24
tar@@ 24
te 24
used. 24
within 24
%. 23
(See 23
1,@@ 23
10@@ 23
6.1 23
CI: 23
Dis@@ 23
NMS 23
ab@@ 23
accordance 23
benefits 23
cancer. 23
ce@@ 23
ents: 23
five 23
food 23
hormon@@ 23
hydrox@@ 23
inf@@ 23
infec@@ 23
injection, 23
intravenously 23
lin@@ 23
list 23
mb@@ 23
medicine. 23
micrograms 23
original 23
period 23
s), 23
sight 23
st 23
storage 23
the@@ 23
thy@@ 23
tion. 23
tissue 23
tongue, 23
transfusion@@ 23
unused 23
upper 23
use, 23
use@@ 23
valu@@ 23
(C@@ 22
(Hb 22
(glass) 22
(i. 22
18@@ 22
5.2 22
53 22
98 22
Blood 22
Gastrointestinal 22
Intravenous 22
Medicinal 22
adjusted 22
al, 22
ass 22
avoided. 22
characteristics 22
cular 22
ded. 22
def@@ 22
dia@@ 22
dl) 22
dl. 22
e: 22
eding 22
end 22
erythro@@ 22
generally 22
gra@@ 22
hours. 22
hypotension 22
infection 22
l 22
lact@@ 22
material 22
medicines, 22
minimise 22
mono@@ 22
neck 22
nerv@@ 22
nes@@ 22
occur. 22
open-label 22
outer 22
phosp@@ 22
presence 22
produced 22
requirements. 22
risks 22
serious 22
sor@@ 22
table@@ 22
tif@@ 22
tility 22
trials. 22
tting 22
ving 22
vivo 22
waste 22
weight, 22
/www. 21
25% 21
32 21
39@@ 21
4.6 21
42 21
5.1 21
5.3 21
5.3). 21
6-@@ 21
6.2 21
6.4 21
6.5 21
67 21
9@@ 21
AN@@ 21
Agency 21
Dose 21
Nervous 21
Sy@@ 21
[@@ 21
adults 21
advised 21
age, 21
anaemia, 21
and/ 21
anti-@@ 21
ask 21
assessment 21
at, 21
bloo@@ 21
blurred 21
cardiac 21
cells. 21
conf@@ 21
constipation, 21
container 21
continu@@ 21
defined 21
determined 21
develop@@ 21
disease. 21
disposal 21
fatigue 21
formation 21
frequent 21
gs 21
he@@ 21
ho@@ 21
http: 21
im@@ 21
indicates 21
indicating 21
indication 21
injection: 21
intoxic@@ 21
invol@@ 21
ity: 21
kalaemia 21
large 21
led 21
lowest 21
lung, 21
means 21
mes 21
moisture. 21
month, 21
my@@ 21
necessary, 21
ness, 21
observed. 21
occurrence 21
particularly 21
pharmac@@ 21
pl@@ 21
procedu@@ 21
production. 21
pulmonary 21
ques@@ 21
radiation 21
responded 21
result 21
rin@@ 21
ris@@ 21
sec@@ 21
sia, 21
sis. 21
sis@@ 21
situ@@ 21
sleep@@ 21
soon 21
spec@@ 21
stabbing 21
stable 21
status, 21
stimulate 21
stimulates 21
swelling 21
systemic 21
tion), 21
tumours 21
underlying 21
undesirable 21
urin@@ 21
variability, 21
vomiting, 21
weighed 21
(0.62 20
(ESAs) 20
(T@@ 20
(greater 20
-like@@ 20
0% 20
20%. 20
20,000/ 20
34 20
3x/ 20
4.1 20
4.2. 20
4.25 20
4.5 20
4.7 20
45 20
56 20
6.1. 20
6.3 20
6.6 20
600 20
61 20
ATC 20
AUTHORISATION/ 20
Antibody-mediated 20
Aplasi@@ 20
CLINICAL 20
COMPOSITION 20
Cancer 20
Cardiac 20
Consequent@@ 20
Contraindications 20
Dosage 20
Effects 20
FIRST 20
General@@ 20
HOW 20
Hep@@ 20
Hol@@ 20
Hyperten@@ 20
IS 20
Incompatibilities 20
List 20
Method 20
Nature 20
O@@ 20
Over@@ 20
PHARMACOLOGICAL 20
PRC@@ 20
PRCA 20
PROPERTIES 20
Pharmacodynamic 20
Pharmacokinetic 20
Pharmacotherapeutic 20
Preclinical 20
Produc@@ 20
QUALITATIVE 20
QUANTITATIVE 20
RENEWAL 20
REVISION 20
Shelf 20
Starting 20
TEXT 20
Therapeutic 20
Thromboti@@ 20
Vascular 20
WHAT 20
a: 20
accident@@ 20
according 20
account 20
accumul@@ 20
actions 20
addressed 20
aggravation 20
agitation, 20
akathisia 20
album@@ 20
all@@ 20
ally 20
alone. 20
always 20
amino 20
anaemia. 20
ance, 20
aneurysms, 20
ant 20
antibodies 20
antithrombotic 20
appeared 20
assess@@ 20
ation: 20
ations. 20
atory 20
attention 20
avo@@ 20
baseline, 20
behaviour 20
beyond 20
bioavailability 20
breast, 20
burden 20
carbohydrate 20
certain 20
chest 20
consis@@ 20
contain 20
correction 20
crisis 20
cultu@@ 20
d-@@ 20
daily) 20
deficiency@@ 20
delay 20
derived 20
dialy@@ 20
diarrhoe@@ 20
difference 20
differenti@@ 20
dihydrate 20
disease; 20
dl@@ 20
dy 20
e-@@ 20
ed. 20
effectiveness 20
ei@@ 20
el@@ 20
en. 20
encephalopathy-like 20
erythrocy@@ 20
erythropoiesis-stimulating 20
es) 20
es). 20
events, 20
examin@@ 20
excee@@ 20
excessive 20
excipients 20
excipients, 20
excipients. 20
exists 20
expressed 20
fac@@ 20
factor 20
falls 20
favour 20
ferritin 20
fistul@@ 20
forms 20
g-term 20
g/dl 20
gastro-intestinal, 20
geal 20
gender, 20
general 20
ges 20
glycosidic 20
goal 20
group: 20
gu@@ 20
gynaecological, 20
haemolysis, 20
head 20
headach@@ 20
i. 20
ical 20
icient. 20
ily 20
improve 20
in. 20
incorporation 20
indications 20
induce 20
ine@@ 20
infarc@@ 20
infusion 20
ings 20
initiating 20
intra-patient 20
iron, 20
iz@@ 20
j@@ 20
l/ 20
label 20
lactation 20
leafle@@ 20
leaflet, 20
level: 20
ligh@@ 20
limit 20
loss, 20
loss@@ 20
lymphom@@ 20
malignancie@@ 20
malignancies 20
medic@@ 20
men@@ 20
ment, 20
mit@@ 20
mmol/l) 20
mmol/l). 20
molec@@ 20
myeloma, 20
occasional 20
occur, 20
oedema, 20
optim@@ 20
or< 20
or> 20
orally 20
orig@@ 20
ours. 20
outcom@@ 20
pH-adjustment) 20
paid 20
partial 20
patient´s 20
phase 20
physician´s 20
point 20
possible, 20
postoperative 20
prede@@ 20
prefer@@ 20
previous 20
program@@ 20
prolifer@@ 20
randomised, 20
range@@ 20
rarely 20
rats, 20
reac@@ 20
regular 20
reinstitute 20
relative 20
remaining 20
repeated 20
replace@@ 20
reproductive 20
requiring 20
restlessness, 20
revie@@ 20
rising 20
scale, 20
sensitiv@@ 20
serious, 20
session 20
sfac@@ 20
shor@@ 20
signal. 20
since 20
sions 20
sit@@ 20
specific 20
spleen 20
stimulating 20
store 20
stores 20
subcutaneously 20
substitution 20
suggest 20
syn@@ 20
te. 20
technology 20
tional 20
tions, 20
ton. 20
tor@@ 20
toxic 20
unless 20
unt 20
variability 20
variety 20
vary 20
volume. 20
volun@@ 20
warning 20
was@@ 20
week@@ 20
weekly. 20
yield 20
% 19
(3 19
(4 19
-risk 19
1% 19
3A4 19
4.8@@ 19
A, 19
ADMINISTRATION 19
Additional 19
Ask 19
B@@ 19
Before 19
CNS 19
Further 19
Immun@@ 19
Lot 19
Metabolis@@ 19
Non-@@ 19
Renal 19
Scale 19
Tell 19
Use 19
a; 19
accel@@ 19
accomp@@ 19
activ@@ 19
acute 19
akathisia, 19
alter@@ 19
among 19
anaphylactic 19
angioedema 19
antipsychotics 19
anxiety 19
app@@ 19
apparent 19
appe@@ 19
association 19
block@@ 19
c, 19
cardi@@ 19
ced 19
circulation. 19
code: 19
cohol 19
completion 19
complications. 19
consciousness 19
controlled, 19
dehydrogen@@ 19
detec@@ 19
detected 19
double-blind, 19
dru@@ 19
effects, 19
electroly@@ 19
energy, 19
environ@@ 19
enzymes 19
ep@@ 19
epilepsy 19
ergic 19
ers. 19
ertain 19
ever 19
excess 19
exclu@@ 19
excreted 19
expec@@ 19
extrapyramidal 19
failure. 19
feelings 19
fever, 19
find@@ 19
foetus. 19
gain. 19
geometric 19
glycosylated 19
hyperglycaemia, 19
hypertension, 19
ia) 19
ia@@ 19
ici@@ 19
identified 19
impairment. 19
impairment: 19
include@@ 19
induc@@ 19
inflammation 19
ison@@ 19
kidney 19
les, 19
level@@ 19
life-@@ 19
male 19
mat@@ 19
med 19
metabolised 19
method 19
monkeys 19
movements, 19
negative 19
neuropath@@ 19
obesity 19
ological 19
ossification 19
oxetin@@ 19
parameters 19
patient's 19
physician 19
poor 19
posit@@ 19
pregnancy 19
primary 19
prolonged 19
radio@@ 19
rash@@ 19
rate. 19
rates 19
ratio@@ 19
ready 19
regularly 19
rel@@ 19
reproduc@@ 19
res. 19
respectively, 19
rou@@ 19
scal@@ 19
seizu@@ 19
set 19
sis, 19
sis: 19
sively 19
spas@@ 19
state, 19
stomach 19
supportive 19
sweating, 19
temperature 19
tention 19
th 19
tially 19
tiv@@ 19
unchanged 19
unger 19
unusual 19
var@@ 19
ver@@ 19
vitro. 19
wa@@ 19
war@@ 19
weaknes@@ 19
well-controlled 19
while 19
wide@@ 19
women. 19
year@@ 19
yel@@ 19
(EMEA) 18
(NM@@ 18
(dextromethorphan@@ 18
(or 18
.1% 18
12-week 18
3-week, 18
352 18
52-@@ 18
5HT1a 18
5HT2a 18
749 18
77% 18
? 18
AB 18
Abraxane. 18
Ac@@ 18
Although 18
Aminotransferase 18
Anti@@ 18
BELGIUM 18
Belgi@@ 18
C 18
CYP3A4, 18
Cardiovascular 18
Children 18
D2 18
Detailed 18
Disease: 18
Elderly: 18
Gender: 18
HIV 18
L. 18
Management 18
N-dealk@@ 18
N. 18
Neuroleptic 18
PACKAGING 18
PHARMACEUTICALS 18
Potential 18
Psychiatric 18
Risk 18
Sei@@ 18
Smoking 18
Tel.: 18
Thus, 18
Tlf: 18
Tél/ 18
U@@ 18
Upon 18
V. 18
abnormaliti@@ 18
adenom@@ 18
age: 18
alone 18
anorex@@ 18
antagonis@@ 18
antagonist 18
ard@@ 18
arrhythmias@@ 18
attemp@@ 18
atypical 18
bo@@ 18
carcinomas 18
characterised 18
charcoal 18
cirrho@@ 18
coma 18
concentrations. 18
conjugates 18
considered. 18
control. 18
controll@@ 18
convul@@ 18
creatine 18
dementi@@ 18
dementia-related 18
demonstrate 18
developmental 18
diabete@@ 18
diabetes, 18
diabetic 18
distribu@@ 18
dopaminergic 18
dro@@ 18
enzymes. 18
episode@@ 18
er 18
ers, 18
es), 18
eu/ 18
evaluable 18
experienced 18
faeces. 18
fatalities. 18
features, 18
fixed-@@ 18
formed 18
gain: 18
ge, 18
get 18
glycaemia 18
hydroxy 18
hyperglycaemia 18
hyperglycaemia-related 18
hyperosmolar 18
increa@@ 18
inducer 18
ing; 18
inhibitor@@ 18
initiation 18
ketoacidosis 18
ketoconaz@@ 18
kg, 18
laboratory 18
lithium@@ 18
lower, 18
m. 18
mal 18
metabolic 18
metabolisers 18
metabolite, 18
oh@@ 18
one-half 18
ousness, 18
panc@@ 18
pathwa@@ 18
pre-@@ 18
predispose 18
predomin@@ 18
pregnant, 18
presents 18
prevention 18
prolong@@ 18
prolongation 18
propo@@ 18
proportion 18
quinid@@ 18
rac@@ 18
range: 18
reaction, 18
reatine 18
receptor 18
reconstituted 18
recovered 18
reductions 18
remission 18
reported. 18
republika 18
rhabdomyolysis, 18
sants 18
sed. 18
seizure 18
seizure, 18
sion* 18
smo@@ 18
smok@@ 18
stem 18
stroke, 18
suici@@ 18
suicidal 18
sulphate 18
superiority 18
tachycardia, 18
tardive 18
ther@@ 18
tose 18
ts, 18
ts: 18
ulation 18
us: 18
ut@@ 18
ven 18
withdrawn 18
worsening 18
years; 18
ylation 18
yo@@ 18
Τηλ: 18
(2@@ 17
0.7 17
17 17
17@@ 17
4.@@ 17
84 17
BLISTERS 17
En@@ 17
I@@ 17
Malignant 17
Medice 17
Syndrome 17
ag@@ 17
anc@@ 17
ate, 17
blood, 17
d@@ 17
doctor@@ 17
en 17
es@@ 17
il 17
imal 17
me 17
meals. 17
metabolis@@ 17
mg. 17
number 17
other@@ 17
our 17
paclitaxel. 17
part 17
rea@@ 17
read 17
reme@@ 17
sequ@@ 17
sodi@@ 17
stat@@ 17
studi@@ 17
tal@@ 17
ther 17
ton 17
too 17
ved 17
%) 16
(10000 16
(> 16
(N= 16
); 16
,@@ 16
.@@ 16
1, 16
95% 16
CONTENTS 16
Disorder: 16
H 16
METHOD 16
N@@ 16
ROUTE(S) 16
SUPPLY 16
Schizophrenia: 16
T 16
TAKE 16
absorption 16
acid, 16
common@@ 16
cro@@ 16
development 16
drink 16
ds 16
due 16
equ@@ 16
lose 16
machines, 16
mal@@ 16
mm@@ 16
neutropen@@ 16
once-a-day 16
our@@ 16
ously. 16
per@@ 16
problems 16
rapid@@ 16
ru@@ 16
schedule 16
short-term 16
single-@@ 16
solution. 16
sto@@ 16
subject 16
tablets. 16
ter@@ 16
tra@@ 16
ty, 16
us 16
’ 16
-f@@ 15
03@@ 15
9000 15
AB@@ 15
ACTIVE 15
BE 15
EFFEC@@ 15
ER 15
GmbH 15
IBLE 15
SUBSTANC@@ 15
als 15
asparta@@ 15
assessed 15
both 15
cell@@ 15
conventional 15
direc@@ 15
extent 15
ful 15
hydra@@ 15
hydroxide 15
immediately. 15
ing. 15
lit@@ 15
look@@ 15
ly. 15
month@@ 15
mp@@ 15
mus@@ 15
nat@@ 15
phenyl@@ 15
precip@@ 15
pyrex@@ 15
recommend@@ 15
sing 15
sion, 15
stability 15
transport 15
ular 15
vigilance 15
women 15
(2°C 14
(IU) 14
(including 14
16. 14
57 14
= 14
Adminis@@ 14
Al@@ 14
Arzneimittel 14
Co 14
Po@@ 14
Pütter 14
Tar@@ 14
aemi@@ 14
agit@@ 14
altered 14
ate@@ 14
ational 14
b 14
bio@@ 14
cancer, 14
cauti@@ 14
ched 14
cont@@ 14
crystalline 14
deficienc@@ 14
discontinued 14
distribution 14
don@@ 14
duc@@ 14
ents. 14
et. 14
evaluated 14
gre@@ 14
headache, 14
ht 14
in, 14
in-@@ 14
international 14
isation 14
kno@@ 14
ly@@ 14
made 14
managed 14
manifestations 14
micro@@ 14
mild 14
occurs 14
orthostatic 14
pain@@ 14
perc@@ 14
pres@@ 14
re 14
shak@@ 14
solu@@ 14
stear@@ 14
studied 14
thoroughly 14
trans@@ 14
ufacturer 14
visi@@ 14
whom 14
x@@ 14
y: 14
°C 14
0.3 13
016 13
11. 13
13. 13
14. 13
15. 13
15.@@ 13
18.@@ 13
23 13
37 13
4-@@ 13
40 13
65 13
7000 13
8.@@ 13
80 13
8°C). 13
ADDRESS 13
APPROPRIATE 13
An@@ 13
BRAILLE 13
C) 13
CHILDREN 13
CLASSIFICATION 13
D-58638 13
DERIVED 13
DISPOSAL 13
EXCIPIENTS 13
FROM 13
GENERAL 13
IN 13
INSTRUCTIONS 13
IT 13
Kuhloweg 13
LEAFLE@@ 13
LIST 13
Lon@@ 13
MATERIALS 13
MINIMUM 13
MUST 13
N-@@ 13
NECESSARY 13
OUT 13
PACKAGE 13
PRECAUTIONS 13
PRODUCTS 13
PRODUCTS, 13
Package 13
Paclitaxel 13
RE@@ 13
REACH 13
RES@@ 13
SIGHT 13
SS@@ 13
STATEMENT 13
STORAGE 13
STORED 13
SUCH 13
Skin 13
THAT 13
UNUSED 13
WARNING 13
WARNING(S), 13
WASTE 13
advice 13
alised 13
ame 13
aripiprazol@@ 13
ately 13
ations, 13
ations: 13
blister. 13
ca@@ 13
cap@@ 13
case 13
cases. 13
chloric 13
chloride 13
col@@ 13
cour@@ 13
ction 13
current 13
cyclo@@ 13
d). 13
den@@ 13
detailed 13
different 13
dihydrogen 13
dizz@@ 13
effec@@ 13
emb@@ 13
ess 13
eyes, 13
fer@@ 13
fl@@ 13
for@@ 13
fra@@ 13
freeze. 13
frequently 13
gener@@ 13
gia 13
han@@ 13
har@@ 13
hypersensitivity 13
ided 13
impact 13
initi@@ 13
int@@ 13
investig@@ 13
ion 13
ist 13
ll@@ 13
mark@@ 13
media@@ 13
mouth 13
new 13
ob@@ 13
om@@ 13
ously 13
performe@@ 13
performing 13
pregn@@ 13
prescrip@@ 13
provi@@ 13
provided 13
qu@@ 13
qual@@ 13
rash, 13
refrigerated 13
remove 13
requ@@ 13
schizophrenia, 13
se, 13
sections 13
sedation 13
slowly 13
sp@@ 13
ste@@ 13
stopped 13
subst@@ 13
syrin@@ 13
ta@@ 13
tent 13
tiredness 13
told 13
tory 13
tr@@ 13
transfer@@ 13
ts@@ 13
tub@@ 13
upon 13
ure 13
ve@@ 13
ven@@ 13
weakness, 13
1,000, 12
100, 12
144 12
15@@ 12
2). 12
2007 12
20@@ 12
35@@ 12
36 12
37@@ 12
43 12
5.1@@ 12
50@@ 12
64 12
900 12
97 12
AR@@ 12
Ad@@ 12
Always 12
B, 12
BE@@ 12
CARTON 12
Chronic 12
Cle@@ 12
Excipi@@ 12
F@@ 12
Increased 12
Median 12
Orodispersible 12
Studies 12
Survival 12
] 12
acc@@ 12
addition 12
administer 12
administr@@ 12
affec@@ 12
aid 12
appetite, 12
appro@@ 12
are@@ 12
ates, 12
ator@@ 12
authoris@@ 12
behaviours 12
below. 12
biological 12
blister@@ 12
bottle 12
breast-feeding 12
called 12
chemotherapy. 12
ck@@ 12
colourless 12
concern@@ 12
continued 12
correct 12
cus@@ 12
des 12
diarrhoea 12
dur@@ 12
ele@@ 12
enhan@@ 12
established 12
experiencing 12
expla@@ 12
fatigu@@ 12
fir@@ 12
fol@@ 12
gene 12
gr@@ 12
group@@ 12
hands, 12
hear@@ 12
hel@@ 12
hour 12
humans. 12
ill@@ 12
impa@@ 12
inal 12
ine. 12
is, 12
joint 12
l. 12
lack 12
lactose 12
leu@@ 12
machines. 12
man@@ 12
measures 12
micronucleus 12
mil@@ 12
mission 12
muscle@@ 12
myelo@@ 12
og@@ 12
oxide 12
painful 12
pharmacological 12
placebo, 12
possibly 12
powder 12
ral 12
rapid 12
recommended. 12
refrigerator 12
responsible 12
restricted 12
rit@@ 12
scale 12
seen 12
ses, 12
setting 12
simultaneously 12
ss@@ 12
standard 12
stati@@ 12
ster 12
studies. 12
sur@@ 12
suspected 12
sw@@ 12
sy 12
syringe, 12
tamine 12
ted, 12
tes, 12
them 12
tongu@@ 12
ul@@ 12
ule 12
upda@@ 12
uria, 12
usually 12
weeks) 12
weeks, 12
y). 12
y; 12
ye@@ 12
α 12
‘ 12
(23 11
(95% 11
(DVT@@ 11
): 11
100) 11
104 11
111 11
12-@@ 11
121 11
125 11
146 11
165 11
174 11
2000 11
26@@ 11
3-@@ 11
31 11
35 11
375 11
4, 11
40% 11
400 11
43@@ 11
44 11
46 11
48 11
55 11
67@@ 11
70 11
71 11
8.7 11
81 11
85 11
89 11
9.@@ 11
91 11
93 11
99 11
99@@ 11
Ab@@ 11
August 11
BY 11
CH@@ 11
Car@@ 11
DNA 11
Disodium 11
Excipients 11
Eye 11
G-CSF 11
Glyc@@ 11
Its 11
KG 11
Lac@@ 11
Me@@ 11
Musculoskeletal 11
Pack 11
Paediatric 11
Results 11
Th@@ 11
Two 11
UR@@ 11
V@@ 11
Water 11
a-@@ 11
ably 11
across 11
action. 11
adj@@ 11
adjustments 11
advanced 11
ae 11
algia, 11
and, 11
angina 11
animals 11
applic@@ 11
around 11
ase 11
ate) 11
ati@@ 11
attach@@ 11
blisters 11
bon@@ 11
breath@@ 11
brok@@ 11
calibrated 11
canc@@ 11
carcinogenic 11
carried 11
cartons 11
cases, 11
cataly@@ 11
cellulose 11
cellulose, 11
chemotherap@@ 11
ching 11
clearance 11
clearly 11
complic@@ 11
condition@@ 11
conducted 11
connective 11
contraindicated 11
cor@@ 11
corrected 11
cramps, 11
creatin@@ 11
dela@@ 11
depression. 11
dip@@ 11
discard 11
disposition 11
doc@@ 11
dry 11
dyskinesi@@ 11
dyspep@@ 11
e). 11
en, 11
ence 11
entr@@ 11
erythropoietin, 11
erythropoietin@@ 11
essen@@ 11
established. 11
events. 11
except 11
expiry 11
e’ 11
few 11
ger@@ 11
given. 11
haemat@@ 11
haemorrhage 11
hair 11
hibit 11
hold 11
hy@@ 11
hypoten@@ 11
icient 11
icul@@ 11
iden@@ 11
iding 11
ies 11
illnes@@ 11
improvements 11
increasing 11
indicated. 11
iness, 11
inflammation, 11
influence 11
infusion, 11
ing) 11
ingredient 11
injectable 11
injected 11
intervals 11
intoler@@ 11
investigated. 11
ip 11
itching, 11
ium 11
labelled 11
larger 11
las@@ 11
leukopen@@ 11
lig@@ 11
liqu@@ 11
ly: 11
lymphatic 11
m). 11
mar@@ 11
maternal 11
mediate 11
metabolites 11
meth@@ 11
mice). 11
migraine-like 11
minutes, 11
mito@@ 11
ml. 11
monitored. 11
mouth, 11
multi@@ 11
mutagenicity 11
needle 11
ness 11
normal@@ 11
occurs. 11
oesopha@@ 11
often 11
oper@@ 11
oti@@ 11
pa@@ 11
paclitaxel@@ 11
particul@@ 11
period, 11
period. 11
plac@@ 11
pon@@ 11
por@@ 11
practic@@ 11
presenting 11
produce 11
product: 11
products, 11
propyl 11
prur@@ 11
pul@@ 11
pur@@ 11
purpo@@ 11
quickly 11
rash 11
rate, 11
ratio 11
recent 11
reconstitu@@ 11
regimen 11
region@@ 11
requires 11
res, 11
results 11
retion 11
return@@ 11
ri@@ 11
rig@@ 11
rubber@@ 11
ry 11
samp@@ 11
seal 11
seeing 11
ses: 11
sho@@ 11
showed 11
sign@@ 11
significance 11
sol@@ 11
som@@ 11
somewhat 11
specifically 11
sper@@ 11
st, 11
stabil@@ 11
sten@@ 11
sting 11
stom@@ 11
stri@@ 11
sts 11
study. 11
study@@ 11
subcutane@@ 11
suitable 11
supplied 11
surgery. 11
swallow@@ 11
swallowing 11
swit@@ 11
thor@@ 11
thrombocytopen@@ 11
tired@@ 11
tly 11
tors, 11
tre@@ 11
treat@@ 11
treatment: 11
tum@@ 11
tumours, 11
types 11
und 11
up@@ 11
usual 11
ved. 11
vomiting 11
weigh@@ 11
wn@@ 11
wor@@ 11
years. 11
yl 11
ys. 11
” 11
! 10
"Flu@@ 10
(10 10
(100 10
(172 10
(221 10
(43%) 10
(683 10
(8.@@ 10
(BES@@ 10
(CLAS). 10
(FACT-An) 10
(Hb@@ 10
(RR 10
(appro@@ 10
(approximately 10
(bone 10
(cerebral 10
(day 10
(days 10
(gl@@ 10
(haematocrit 10
(haemoglobin 10
(hyper@@ 10
(injection@@ 10
(iron 10
(kg 10
(loss 10
(most 10
(mouse 10
(normal 10
(patient 10
(please 10
(this 10
(two 10
(with 10
)< 10
-filled 10
-on 10
-reaction. 10
.). 10
.6% 10
0). 10
06, 10
08 10
1,18; 10
1000 10
16@@ 10
1800 10
1895 10
19% 10
2-@@ 10
21, 10
27% 10
2833 10
3%). 10
3, 10
301 10
32% 10
32,@@ 10
332 10
389 10
3H-@@ 10
45@@ 10
478 10
5%), 10
58% 10
59@@ 10
6769 10
68% 10
7) 10
71% 10
721 10
78@@ 10
800 10
802 10
8167 10
ABILIFY: 10
Abraxan@@ 10
Anagni-Frosinone 10
Analogue 10
Appro@@ 10
Assessment 10
At@@ 10
B03XA01 10
Brea@@ 10
Bristol-Myers 10
CLA@@ 10
CYP3A@@ 10
Care 10
Ceraso 10
Chan@@ 10
Contrada 10
Cyto@@ 10
D 10
DE 10
DVT@@ 10
Dialy@@ 10
Dri@@ 10
Dyspha@@ 10
EORTC-QLQ-C30 10
ESA@@ 10
Early 10
El@@ 10
Epre@@ 10
Erythropoietin@@ 10
FACT-An 10
FOR@@ 10
FUR@@ 10
Fac@@ 10
Fe-@@ 10
Fe2+ 10
Fontana 10
Functional 10
GM-CSF 10
Good 10
Hodgkin@@ 10
Howe@@ 10
Hydro@@ 10
I) 10
I-03012 10
IP@@ 10
IU 10
IU) 10
Imp@@ 10
Iserlohn 10
Ital@@ 10
J@@ 10
Jun@@ 10
Leafle@@ 10
Lik@@ 10
Linear 10
MA@@ 10
Man@@ 10
Met@@ 10
Mil@@ 10
N 10
Non 10
O 10
O-@@ 10
Occ@@ 10
PANSS 10
PO@@ 10
Parti@@ 10
Pharmacokineti@@ 10
Phlebotom@@ 10
Please 10
Polysorb@@ 10
Pre@@ 10
RF) 10
Rec@@ 10
S, 10
SI@@ 10
STOR@@ 10
STR@@ 10
Schizophren@@ 10
Ser@@ 10
Sh@@ 10
Si@@ 10
Squibb 10
Su@@ 10
Sur@@ 10
T: 10
THER 10
TS 10
TVEs 10
Tak@@ 10
Therap@@ 10
Thromb@@ 10
Tum@@ 10
US@@ 10
USED 10
Usu@@ 10
VE@@ 10
X 10
YOU 10
YYYY} 10
[6.2 10
a) 10
a-related 10
abo@@ 10
absor@@ 10
achie@@ 10
acid@@ 10
addi@@ 10
adul@@ 10
adver@@ 10
again@@ 10
agon@@ 10
ai@@ 10
air@@ 10
alan@@ 10
aled 10
alkal@@ 10
all, 10
alop@@ 10
am 10
ambul@@ 10
amo@@ 10
amp@@ 10
anced 10
anied 10
ann@@ 10
ans 10
anter@@ 10
antly 10
arance 10
arin@@ 10
asure@@ 10
avoide@@ 10
bacter@@ 10
bal@@ 10
bb@@ 10
benef@@ 10
bi@@ 10
bing 10
blastopen@@ 10
ble 10
body-@@ 10
body-mediated 10
bol@@ 10
bond 10
c. 10
c/ 10
carcin@@ 10
chains 10
ches 10
chosen 10
cl@@ 10
come 10
control@@ 10
conven@@ 10
cope, 10
core 10
correc@@ 10
cs 10
cur@@ 10
cy 10
dal@@ 10
depen@@ 10
dependent 10
derly 10
determin@@ 10
develo@@ 10
diff@@ 10
disorder@@ 10
dl). 10
dly 10
dness, 10
donation 10
dou@@ 10
double-blin@@ 10
d”@@ 10
e., 10
early 10
ef@@ 10
elimin@@ 10
embol@@ 10
emboli@@ 10
emed 10
enable 10
ence, 10
end@@ 10
endogen@@ 10
ene 10
ens 10
ep 10
erate 10
erated 10
erature 10
ern 10
erythropoiet@@ 10
est 10
esti@@ 10
estima@@ 10
etc.). 10
eti@@ 10
etylsalic@@ 10
evalu@@ 10
ever@@ 10
exces@@ 10
explained 10
extra@@ 10
e”@@ 10
fall 10
fast 10
feren@@ 10
fill@@ 10
fre@@ 10
fro@@ 10
fung@@ 10
ga@@ 10
gia, 10
gin 10
glyco@@ 10
gno@@ 10
go 10
gram@@ 10
gree 10
gy, 10
haematocrit 10
haemo@@ 10
haemoly@@ 10
half-@@ 10
haryn@@ 10
hydration, 10
hypertensive 10
ial, 10
ian 10
ically 10
idis@@ 10
ig@@ 10
igh@@ 10
immun@@ 10
inade@@ 10
incont@@ 10
inde@@ 10
ine) 10
ine-@@ 10
inflamm@@ 10
injection@@ 10
insomn@@ 10
insti@@ 10
instrum@@ 10
insufficienc@@ 10
intak@@ 10
intraven@@ 10
io@@ 10
ior 10
is. 10
ischaemi@@ 10
isoton@@ 10
itus, 10
jerk@@ 10
l)@@ 10
l], 10
le-@@ 10
len 10
lief@@ 10
lying 10
m2 10
males 10
manage@@ 10
mate 10
men 10
mid@@ 10
migra@@ 10
minim@@ 10
minu@@ 10
mitte@@ 10
mm3 10
mmol 10
mon 10
monke@@ 10
nei@@ 10
neur@@ 10
ng/ 10
nu@@ 10
nucle@@ 10
od. 10
onar@@ 10
operative 10
or, 10
os@@ 10
oses, 10
oxy@@ 10
para@@ 10
parathy@@ 10
partic@@ 10
particip@@ 10
patibil@@ 10
pectoris, 10
pha@@ 10
phlebotom@@ 10
phosphatase 10
physici@@ 10
pig@@ 10
pla@@ 10
position 10
post@@ 10
presen@@ 10
priate 10
propor@@ 10
rang@@ 10
re) 10
reaction. 10
ref@@ 10
regul@@ 10
rements 10
require@@ 10
resi@@ 10
respec@@ 10
resses 10
resul@@ 10
revision 10
rhyth@@ 10
rin 10
rings 10
role 10
rolit@@ 10
sal@@ 10
sat@@ 10
sati@@ 10
schizophren@@ 10
sha@@ 10
sis-stimulating 10
slower 10
sm@@ 10
spirator@@ 10
spor@@ 10
ssible 10
stage@@ 10
state 10
step@@ 10
stimul@@ 10
strok@@ 10
sure@@ 10
surger@@ 10
suspec@@ 10
sweat@@ 10
sy@@ 10
system@@ 10
t: 10
tachycardia@@ 10
tanc@@ 10
tation 10
ten 10
tex@@ 10
thro@@ 10
thrombo@@ 10
tical 10
til@@ 10
tinal 10
tment. 10
ton@@ 10
tor 10
tors 10
tors. 10
transf@@ 10
trea@@ 10
treated, 10
tri@@ 10
trib@@ 10
trol@@ 10
ture 10
tut@@ 10
twit@@ 10
ubation 10
ult 10
um, 10
um. 10
uncle@@ 10
und, 10
ung 10
unknown 10
unstable 10
untary 10
untreated, 10
ure. 10
urea@@ 10
urg@@ 10
utive 10
ve, 10
vei@@ 10
ver 10
ves@@ 10
vestig@@ 10
vie@@ 10
vis@@ 10
vo@@ 10
volume@@ 10
wall@@ 10
weak@@ 10
wh@@ 10
what 10
wing 10
x. 10
x/ 10
xi@@ 10
x”@@ 10
y- 10
ylic 10
ys, 10
yto@@ 10
zen. 10
≤ 10
(0)21 9
(0)810 9
(0800) 9
(30 9
(30%). 9
(57@@ 9
(6%) 9
(ALT), 9
(AST), 9
(Child-Pugh 9
(EPS): 9
(FINLAND) 9
(GGT), 9
(n= 9
-88 9
-controlled 9
-treated 9
., 9
.Ε. 9
.Π 9
000, 9
05 9
1-adren@@ 9
10-30 9
107%, 9
11C-@@ 9
13% 9
1301 9
1736 9
18% 9
195 9
2004 9
200@@ 9
210 9
221 9
228 9
230 9
236 9
251 9
272 9
2790 9
2C19 9
2C9 9
3000 9
314 9
34% 9
351 9
353 9
354 9
357 9
358 9
359 9
370 9
371 9
372 9
386 9
4.4) 9
410 9
42-0 9
420 9
421 9
440 9
456 9
47%. 9
500 9
535 9
57% 9
5796666 9
59298411 9
5HT2@@ 9
5HT7@@ 9
60% 9
6074300 9
640 9
677038 9
69% 9
704 9
73% 9
73%). 9
731 9
762 9
8%) 9
800) 9
857 9
938@@ 9
9700 9
99% 9
AUC) 9
Addi@@ 9
Alan@@ 9
Alzheim@@ 9
Antidepres@@ 9
Aspart@@ 9
BV 9
Belgique@@ 9
CO. 9
CPK 9
CYP1@@ 9
CYP1A@@ 9
CYP2D6, 9
CYP2D6. 9
D2@@ 9
Danmark 9
Depres@@ 9
Deutschland 9
Dur@@ 9
Eesti 9
Elimination: 9
España 9
Extrapyramid@@ 9
FARMACÊUTICA 9
Finland 9
France 9
GESMBH 9
GMBH 9
Gluta@@ 9
HF 9
Ireland 9
Italia 9
KGAA 9
Latvija 9
Lietuva 9
Luxembour@@ 9
Luxemburg 9
Magyarország 9
Malta 9
Matern@@ 9
Montgomery-Asber@@ 9
N05AX12 9
NORWAY 9
Nederland 9
Norge 9
OY 9
POLSKA 9
PORTUGUESA, 9
Pharmaco@@ 9
Phosphokinase), 9
Phosphokinase, 9
Polska 9
Pop@@ 9
Portugal 9
Post-Marketing: 9
Prec@@ 9
Puh@@ 9
RMP 9
Rac@@ 9
România 9
S), 9
S): 9
SARL 9
SP. 9
SQUIBB, 9
Slovenija 9
Slovenská 9
St@@ 9
Suomi@@ 9
Sverige 9
Sími: 9
Teл.: 9
There@@ 9
Tox@@ 9
Transferase 9
Tél: 9
VISTOR 9
Wort@@ 9
Z 9
]@@ 9
abil@@ 9
able@@ 9
absolute 9
ach@@ 9
ade@@ 9
adolesc@@ 9
adren@@ 9
ady 9
age. 9
agonis@@ 9
alac@@ 9
alpha-@@ 9
amm@@ 9
ank@@ 9
antipsychotic@@ 9
apis@@ 9
ardi@@ 9
asymptomati@@ 9
at-@@ 9
atitis, 9
auton@@ 9
azep@@ 9
ba@@ 9
bet@@ 9
bidi@@ 9
bil@@ 9
bin@@ 9
body@@ 9
breast-fe@@ 9
ci@@ 9
cling 9
conaz@@ 9
concentr@@ 9
conduc@@ 9
consider@@ 9
d? 9
dat@@ 9
death@@ 9
decrea@@ 9
del 9
demen@@ 9
der: 9
deter@@ 9
dic@@ 9
differenc@@ 9
ding@@ 9
dio@@ 9
disea@@ 9
dispose 9
dos@@ 9
dra@@ 9
e-treated 9
eep 9
eh@@ 9
elec@@ 9
emi@@ 9
enchy@@ 9
epidemi@@ 9
erebrovascular 9
erent 9
erg@@ 9
esc@@ 9
eská 9
establis@@ 9
experienc@@ 9
exposu@@ 9
extre@@ 9
farin), 9
fataliti@@ 9
feat@@ 9
fin@@ 9
flexib@@ 9
fore 9
fort@@ 9
gain@@ 9
ger 9
globinur@@ 9
haz@@ 9
hidro@@ 9
his@@ 9
hokinase 9
hokinase, 9
hydroxybenzo@@ 9
ia: 9
ice 9
icid@@ 9
ido@@ 9
iety 9
igen@@ 9
ility 9
impairment@@ 9
inhal@@ 9
ink 9
ink@@ 9
inn@@ 9
intes, 9
intramus@@ 9
ipofusc@@ 9
ir 9
italopram) 9
itu@@ 9
iv@@ 9
ju@@ 9
keto@@ 9
ketoac@@ 9
keton@@ 9
kg) 9
kinsonis@@ 9
lass 9
le 9
lev@@ 9
lexib@@ 9
lor@@ 9
low@@ 9
lower@@ 9
lowing 9
malign@@ 9
mellitus, 9
ment. 9
metabol@@ 9
mic 9
mode@@ 9
mortal@@ 9
motid@@ 9
myo@@ 9
national 9
necessar@@ 9
od 9
oedema 9
ogenic 9
ograph@@ 9
ole@@ 9
olelithiasis 9
oleptic 9
on. 9
ople 9
ortant 9
ould 9
ous, 9
oxymorphin@@ 9
oz@@ 9
pass@@ 9
path@@ 9
phy@@ 9
placebo@@ 9
plas@@ 9
potenti@@ 9
present@@ 9
prote@@ 9
rady@@ 9
raz@@ 9
re, 9
reatitis, 9
recover@@ 9
recur@@ 9
relev@@ 9
relevan@@ 9
ren@@ 9
repe@@ 9
reve@@ 9
rhabdomyoly@@ 9
rhythmi@@ 9
rine 9
ron 9
se) 9
sed@@ 9
sel 9
sel@@ 9
sensor@@ 9
signific@@ 9
siz@@ 9
sle@@ 9
spha@@ 9
st-fe@@ 9
stab@@ 9
stiff@@ 9
ston@@ 9
subjec@@ 9
sugge@@ 9
suicid@@ 9
t-@@ 9
te; 9
temp@@ 9
thermi@@ 9
tiazem 9
tion; 9
tom@@ 9
trial@@ 9
tro@@ 9
tumor@@ 9
unchange@@ 9
unts 9
usu@@ 9
uta@@ 9
van@@ 9
ver, 9
ves 9
vi@@ 9
vision 9
vol@@ 9
ways 9
weig@@ 9
x, 9
yngospas@@ 9
zu@@ 9
{MM@@ 9
~@@ 9
Ísland 9
Österreich 9
ë@@ 9
Č 9
ΑΚΗΣ 9
Ε 9
Ελλάδα 9
Κύπρος 9
ΠΑΝΑΓΙΩΤΟΥ 9
ΥΙΟΣ 9
България 9
(*@@ 8
(n 8
1/100). 8
1/10@@ 8
1/@@ 8
29 8
3-5 8
87%. 8
Abilif@@ 8
Diabetes 8
Dyskinesi@@ 8
FAC@@ 8
IC@@ 8
ING 8
IT@@ 8
L 8
LI@@ 8
Mell@@ 8
NE@@ 8
Plan 8
TIONS 8
TR@@ 8
Ver@@ 8
act 8
altern@@ 8
bed 8
cal@@ 8
de. 8
eral 8
fla@@ 8
hosp@@ 8
hydroxy@@ 8
if@@ 8
ile 8
imp@@ 8
main 8
occur@@ 8
presc@@ 8
rence 8
ron@@ 8
sion. 8
some@@ 8
sour@@ 8
ssion 8
star@@ 8
sul@@ 8
sulf@@ 8
ter, 8
ties 8
tivi@@ 8
uman 8
undergo@@ 8
us. 8
ust@@ 8
(P@@ 7
109@@ 7
11@@ 7
14, 7
19 7
28, 7
Abseame@@ 7
EL@@ 7
LE@@ 7
Ma@@ 7
Magnesi@@ 7
Per@@ 7
Sc@@ 7
Y@@ 7
al. 7
alent 7
au@@ 7
comp@@ 7
fru@@ 7
glyc@@ 7
gnesi@@ 7
hed 7
marketing 7
ol 7
propyl@@ 7
sion@@ 7
swal@@ 7
thracyclin@@ 7
ub@@ 7
wn 7
"6@@ 6
"A" 6
(44-20) 6
(CHMP) 6
(E172) 6
(E172). 6
(E2@@ 6
(E951) 6
1.8.@@ 6
27 6
30@@ 6
A-00@@ 6
CHMP 6
Cros@@ 6
EMEA 6
EPAR 6
EPAR@@ 6
Er@@ 6
K@@ 6
Mo@@ 6
UM@@ 6
UN@@ 6
ack 6
afety 6
carmel@@ 6
contain@@ 6
de-@@ 6
dule 6
edi@@ 6
esi@@ 6
et@@ 6
eu 6
gi@@ 6
gluco@@ 6
harm@@ 6
ied 6
infusion@@ 6
ita@@ 6
ketonur@@ 6
la@@ 6
linical 6
lis@@ 6
mail@@ 6
mg@@ 6
ms 6
n, 6
on, 6
pH-adjustment@@ 6
povid@@ 6
ros@@ 6
se-@@ 6
silic@@ 6
skin@@ 6
so@@ 6
speci@@ 6
spen@@ 6
ss 6
st-@@ 6
stitution 6
tary 6
tryp@@ 6
und@@ 6
ute 6
ylit@@ 6
(S) 5
100@@ 5
2) 5
26 5
480 5
5000 5
6, 5
8000 5
9% 5
AF@@ 5
Bio@@ 5
Ch@@ 5
Erypo 5
IATE 5
IM@@ 5
MED@@ 5
MP@@ 5
NG 5
ONS@@ 5
Pack@@ 5
RAX@@ 5
Ro@@ 5
TIVE 5
U 5
UK 5
X@@ 5
am@@ 5
author@@ 5
cal 5
che@@ 5
cle@@ 5
contra@@ 5
er. 5
erat@@ 5
eren@@ 5
eth@@ 5
euro@@ 5
expo@@ 5
ge 5
ha@@ 5
ib@@ 5
ip@@ 5
lac@@ 5
lymph@@ 5
mu@@ 5
ore@@ 5
pen@@ 5
pp@@ 5
proble@@ 5
prof@@ 5
ree 5
rigidi@@ 5
so 5
ster@@ 5
tain@@ 5
tis 5
tt@@ 5
vent@@ 5
yp@@ 5
(1.@@ 4
(1@@ 4
*@@ 4
.5 4
0,@@ 4
012 4
47@@ 4
80@@ 4
Abrax@@ 4
Alumin@@ 4
App@@ 4
B. 4
Be@@ 4
CHMP@@ 4
CI@@ 4
Cal@@ 4
EU@@ 4
Gra@@ 4
Hydroxy@@ 4
II@@ 4
Par@@ 4
Ra@@ 4
addre@@ 4
adminis@@ 4
ang@@ 4
ates 4
behavi@@ 4
bott@@ 4
bu@@ 4
carton@@ 4
dex@@ 4
dr@@ 4
el 4
gent@@ 4
gl@@ 4
go@@ 4
hat 4
hydrate 4
ience 4
ince 4
ined 4
ins 4
inte@@ 4
iph@@ 4
ith@@ 4
ment@@ 4
metasta@@ 4
mg/ml 4
mouth@@ 4
n. 4
nau@@ 4
o 4
ocy@@ 4
odium 4
physi@@ 4
previ@@ 4
protec@@ 4
reased 4
recon@@ 4
rop@@ 4
se: 4
secon@@ 4
stand 4
stu@@ 4
ter. 4
tic@@ 4
ure, 4
us, 4
us@@ 4
utrop@@ 4
utrophil@@ 4
vigil@@ 4
with@@ 4
’@@ 4
(AUC) 3
(E@@ 3
(EP@@ 3
(R@@ 3
(allerg@@ 3
--------------------------------@@ 3
1) 3
62 3
72 3
78 3
@@@ 3
AC@@ 3
Asparta@@ 3
BLIST@@ 3
CHAR@@ 3
CYP2@@ 3
Char@@ 3
ED 3
EME@@ 3
EP@@ 3
ES@@ 3
ET@@ 3
Fa@@ 3
For@@ 3
HT@@ 3
IS@@ 3
Inf@@ 3
Intra@@ 3
Iserloh@@ 3
KG@@ 3
MAR@@ 3
ME@@ 3
MENT 3
MPO@@ 3
Neutropen@@ 3
OL@@ 3
OR@@ 3
Phenylketonur@@ 3
Pl@@ 3
Pregn@@ 3
Q 3
RO@@ 3
SMA@@ 3
SP@@ 3
Spec@@ 3
TER@@ 3
TIC@@ 3
Tel@@ 3
UB@@ 3
Up@@ 3
Van@@ 3
WEI@@ 3
Wel@@ 3
Y 3
absorp@@ 3
ack@@ 3
acter@@ 3
af@@ 3
age@@ 3
ale 3
bat@@ 3
chlor@@ 3
colour@@ 3
difficul@@ 3
dizzin@@ 3
dri@@ 3
dy. 3
ed@@ 3
ede@@ 3
ee 3
eight 3
eng@@ 3
ept 3
erk@@ 3
ern@@ 3
est@@ 3
ey@@ 3
g, 3
ge. 3
ges@@ 3
health@@ 3
hydro@@ 3
hydroxi@@ 3
ien@@ 3
ild@@ 3
ingredi@@ 3
iti@@ 3
lak@@ 3
lease 3
less@@ 3
lex@@ 3
lic 3
machin@@ 3
main@@ 3
medi@@ 3
ms, 3
odi@@ 3
ok@@ 3
ort 3
ough@@ 3
pared 3
pe@@ 3
ple@@ 3
potassi@@ 3
reat@@ 3
remo@@ 3
rub@@ 3
sensi@@ 3
ser@@ 3
ses. 3
sible 3
sin@@ 3
sity 3
son@@ 3
sorb@@ 3
spira@@ 3
stop@@ 3
tal 3
tely 3
ters 3
thorisation 3
tis, 3
umber 3
wder 3
y) 3
(*) 2
(S@@ 2
(n@@ 2
/@@ 2
000@@ 2
20.@@ 2
4% 2
5% 2
59 2
69 2
83 2
88 2
90 2
95 2
A-@@ 2
Agen@@ 2
Alo@@ 2
Ar@@ 2
B 2
BER 2
Bre@@ 2
D-@@ 2
DE@@ 2
De@@ 2
Diff@@ 2
Dise@@ 2
Dy@@ 2
ES 2
EXP@@ 2
Eff@@ 2
G 2
GE 2
IN@@ 2
IV@@ 2
Inter@@ 2
Lt@@ 2
MEN@@ 2
Meta@@ 2
OLOGICAL 2
STAT@@ 2
TE@@ 2
UL@@ 2
aclitaxel 2
aclitaxel@@ 2
amin@@ 2
analy@@ 2
and@@ 2
ange 2
ast 2
att@@ 2
benzo@@ 2
ber 2
bili@@ 2
blu@@ 2
bur@@ 2
can@@ 2
concomit@@ 2
constip@@ 2
curr@@ 2
dig@@ 2
divi@@ 2
dose-@@ 2
dynamic 2
eb@@ 2
ects 2
ein@@ 2
ek 2
enc@@ 2
endo@@ 2
ess, 2
ess@@ 2
exc@@ 2
experim@@ 2
f 2
fun@@ 2
ged 2
gle@@ 2
glo@@ 2
gro@@ 2
hand@@ 2
hil@@ 2
hin@@ 2
hr@@ 2
ide 2
idne@@ 2
ild-@@ 2
illed 2
immediate@@ 2
itch@@ 2
ity, 2
jec@@ 2
ke@@ 2
kidne@@ 2
lowed 2
mino@@ 2
not@@ 2
off@@ 2
ogen@@ 2
omen 2
onc@@ 2
organ@@ 2
ose 2
ours, 2
pec@@ 2
perfor@@ 2
perio@@ 2
phen@@ 2
pr@@ 2
py@@ 2
que@@ 2
recep@@ 2
recommen@@ 2
remain@@ 2
replac@@ 2
sc@@ 2
sch@@ 2
sea, 2
short@@ 2
skele@@ 2
somnol@@ 2
ss, 2
st. 2
stan@@ 2
stand@@ 2
sterile@@ 2
suppor@@ 2
tained 2
technolog@@ 2
though@@ 2
tial 2
treatment@@ 2
ty 2
umul@@ 2
under@@ 2
usion@@ 2
vation 2
vomit@@ 2
wir@@ 2
y-@@ 2
ys 2
zep@@ 2
© 2
©@@ 2
°C@@ 2
µ@@ 2
β 2
%), 1
(4@@ 1
(6@@ 1
(7@@ 1
(D@@ 1
)@@ 1
----------------@@ 1
--------@@ 1
.: 1
00-@@ 1
01 1
05@@ 1
06@@ 1
07@@ 1
1-@@ 1
167 1
27@@ 1
28@@ 1
29@@ 1
2C@@ 1
38 1
38@@ 1
3A@@ 1
5.3@@ 1
52 1
66 1
AL 1
ALT 1
Akathis@@ 1
Album@@ 1
All@@ 1
As@@ 1
Au@@ 1
CO@@ 1
Cma@@ 1
Dat@@ 1
Differen@@ 1
Disorder@@ 1
ER@@ 1
Exc@@ 1
Fatigu@@ 1
Fatigue 1
Flu@@ 1
Fru@@ 1
Hae@@ 1
Hy@@ 1
Hypo@@ 1
IRY 1
Ju@@ 1
LA@@ 1
LE 1
Lymph@@ 1
Myal@@ 1
NA@@ 1
Na@@ 1
Ne@@ 1
Neuropath@@ 1
Os@@ 1
PR@@ 1
Pha@@ 1
Poly@@ 1
Pri@@ 1
Pro@@ 1
R 1
Random@@ 1
ST 1
SU@@ 1
Sol@@ 1
Stra@@ 1
Sul@@ 1
Symptom@@ 1
T-@@ 1
Ta@@ 1
Tachy@@ 1
Thro@@ 1
Thrombo@@ 1
V 1
We@@ 1
aclitaxel. 1
action 1
advis@@ 1
afet@@ 1
ail@@ 1
ak@@ 1
alk@@ 1
alon@@ 1
als. 1
alumini@@ 1
amma@@ 1
ant, 1
anx@@ 1
appeti@@ 1
arly 1
aspar@@ 1
ass) 1
ass@@ 1
asse@@ 1
ated. 1
ath@@ 1
av@@ 1
ben@@ 1
ble@@ 1
brea@@ 1
carcinom@@ 1
carrie@@ 1
cc@@ 1
chen 1
childr@@ 1
cin@@ 1
cip@@ 1
cle 1
clin@@ 1
common: 1
controlle@@ 1
cra@@ 1
culoskeletal 1
dar@@ 1
defin@@ 1
del@@ 1
demonst@@ 1
den, 1
depend@@ 1
deta@@ 1
diast@@ 1
diation 1
dic 1
discar@@ 1
dle@@ 1
dom@@ 1
dre@@ 1
dyn@@ 1
e), 1
ear@@ 1
ed, 1
ee@@ 1
eff@@ 1
efficac@@ 1
eig@@ 1
ein, 1
ein. 1
elling 1
ely 1
emia 1
en). 1
encephalopath@@ 1
ese 1
et 1
fail@@ 1
favirenz, 1
feel@@ 1
fest@@ 1
ff@@ 1
fore, 1
freez@@ 1
ft 1
gastro@@ 1
gen 1
giv@@ 1
grams 1
gression 1
haematoc@@ 1
hal@@ 1
half 1
hei@@ 1
hen@@ 1
hib@@ 1
hle@@ 1
i-@@ 1
ial@@ 1
icac@@ 1
ication 1
ich 1
icienc@@ 1
icin, 1
ie 1
ign@@ 1
influ@@ 1
inful 1
injec@@ 1
int 1
interv@@ 1
iso@@ 1
istic@@ 1
istics 1
itus 1
jo@@ 1
ks 1
lactic 1
lated 1
ler 1
line, 1
low. 1
ma 1
ma, 1
marro@@ 1
matolog@@ 1
maxim@@ 1
mell@@ 1
men, 1
meta@@ 1
metabolit@@ 1
mg/m2 1
minis@@ 1
mix@@ 1
move@@ 1
multip@@ 1
n 1
ne 1
nec@@ 1
nor@@ 1
obser@@ 1
och@@ 1
ode: 1
oly@@ 1
omit@@ 1
ort: 1
ort@@ 1
osmol@@ 1
oton@@ 1
ough 1
ours 1
ousness 1
pack@@ 1
pector@@ 1
phosphat@@ 1
plan@@ 1
platele@@ 1
possib@@ 1
poten@@ 1
poth@@ 1
precau@@ 1
proce@@ 1
proper@@ 1
r 1
random@@ 1
ras@@ 1
reasing 1
red@@ 1
refrig@@ 1
rep@@ 1
requirement@@ 1
responding 1
reted 1
rho@@ 1
rie@@ 1
ring@@ 1
sely 1
seri@@ 1
sever@@ 1
sf@@ 1
simi@@ 1
sing@@ 1
specif@@ 1
spee@@ 1
spon@@ 1
sta@@ 1
static 1
statisti@@ 1
stitu@@ 1
str@@ 1
sud@@ 1
suit@@ 1
supple@@ 1
t). 1
t; 1
table 1
tane@@ 1
temper@@ 1
tered 1
tern 1
therapie@@ 1
there@@ 1
thoug@@ 1
tic 1
tissu@@ 1
tol@@ 1
toler@@ 1
tran@@ 1
transferase 1
transi@@ 1
tur@@ 1
ue 1
ully 1
ung@@ 1
ure@@ 1
vari@@ 1
virap@@ 1
vit@@ 1
viv@@ 1
ween 1
yn@@ 1
ytoin, 1
zin@@ 1
{MM/@@ 1
°@@ 1
º@@ 1
